Yeungnam Univ J Med.  2016 Dec;33(2):150-154. 10.12701/yujm.2016.33.2.150.

Chronic hepatitis C healed by peginterferon-α and rivabirin treatment after kidney transplantation

Affiliations
  • 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea. green740@naver.com

Abstract

Hepatitis C virus (HCV) infection is present in a high proportion of patients with kidney transplantation. Compared with uninfected kidney transplant recipients, HCV infected kidney recipient have higher prevalence of liver disease and worse allograft survival after transplantation. Interferon monotherapy before transplantation is standard therapy for HCV-infected kidney transplant candidates. If HCV infection is discovered after transplantation, interferon monotherapy is considered due to the limited critical situation. However, in this patient, who was a kidney recipient, HCV infection was treated after kidney transplantation with peginterferon-α and rivabirin. As a result, the patient achieved sustained virologic response.

Keyword

Kidney transplantation; Chronic hepatitis C; Ribavirin; Peginterferon alpha

MeSH Terms

Allografts
Hepacivirus
Hepatitis C, Chronic*
Hepatitis, Chronic*
Humans
Interferons
Kidney Transplantation*
Kidney*
Liver Diseases
Prevalence
Ribavirin
Transplant Recipients
Interferons
Ribavirin
Full Text Links
  • YUJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr